CLINICAL_TRIALS ClinicalTrials.gov record update

Phase 1 Dose Escalation and Expansion Study of HPB-092 to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (RR-AML)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT07137637
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:24.914415+00:00
Published At: 2025-08-22T00:00:00+00:00
Record Updated At: 2025-08-22
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Relapsed and Refractory Acute Myeloid Leukemia (RR-AML)"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-08-22"
protocolSection.identificationModule.nctId: "NCT07137637"
protocolSection.identificationModule.officialTitle: "Phase 1 Dose Escalation and Expansion Study of HPB-092 to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (RR-AML)"
protocolSection.statusModule.overallStatus: "NOT_YET_RECRUITING"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.